Top

Published in:

01-06-2019 | Original Article

Survival analysis of patients with spinal chordomas

Authors: Hui-Hui Sun, Xin Hong, Bing Liu, Jia-Qu Cui, Zhao-Ming Zhou, Xin-Hui Xie, Xiao-Tao Wu

Published in: Neurosurgical Review | Issue 2/2019

Abstract

This study was aimed to analyze the survival of patients with spinal chordomas. Patients’ data in the Surveillance, Epidemiology, and End Results (SEER) database were retrieved and analyzed statistically. There were 765 patients with spinal chordomas between 1974 and 2013. The overall survival did not improve significantly over decades for patients receiving surgery and radiotherapy (SR) (P = 0.221). There were significant differences in overall survival among subgroups of patients receiving surgery (S), radiotherapy (R), and neither S nor R (NSR) (P = 0.031, 0.037, and 0.031, respectively). Cancer-specific survival did not change significantly among subgroups of patients receiving R (P = 0.411), while it increased steadily among subgroups of patients receiving S, SR, and NSR (P < 0.001, 0.001, and 0.049, respectively). In the multivariate Cox regression model, younger onset age (hazard ratio [HR] 1.052, P < 0.001), surgery (HR 0.291, P = 0.001), and tumor location of the sacrum (HR 0.401, P = 0.002) were associated with a better overall survival. Similarly, younger onset age (HR 1.036, P = 0.029), surgery (HR 0.221, P = 0.009), and tumor location of the sacrum (HR 0.287, P = 0.002) were also associated with a higher cancer-specific survival. The changes in overall and cancer-specific survival over time differ among different treatment groups. Younger onset age, surgical strategy, and tumor location of the sacrum may be correlated with a higher overall and cancer-specific survival.

Coindre JM (2012) New WHO classification of tumours of soft tissue and bone J. Ann Pathol 32(5 Suppl):S115–S116CrossRefPubMed

Yang XR, Ng D, Alcorta DA, Liebsch NJ, Sheridan E, Li S, Goldstein AM, Parry DM, Kelley MJ (2009) T (brachyury) gene duplication confers major susceptibility to familial chordoma[J]. Nat Genet 41(11):1176–1178CrossRefPubMedPubMedCentral

Healey JH, Lane JM (1989) Chordoma: a critical review of diagnosis and treatment[J]. Orthop Clin N Am 20(3):417–426

Smoll NR, Gautschi OP, Radovanovic I, Schaller K, Weber DC (2013) Incidence and relative survival of chordomas: the standardized mortality ratio and the impact of chordomas on a population[J]. Cancer 119(11):2029–2037CrossRefPubMed

Lauer SR, Edgar MA, Gardner JM, Sebastian A, Weiss SW (2013) Soft tissue chordomas: a clinicopathologic analysis of 11 cases[J]. Am J Surg Pathol 37(5):719–726CrossRefPubMed

Koutourousiou M, Snyderman CH, Fernandez-Miranda J, Gardner PA (2011) Skull base chordomas[J]. Otolaryngol Clin N Am 44(5):1155–1171CrossRef

Dorfman HD, Czerniak B (1995) Bone cancers[J]. Cancer 75(1 Suppl):203–210CrossRef

Mukherjee D, Chaichana KL, Gokaslan ZL, Aaronson O, Cheng JS, McGirt MJ (2011) Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003[J]. J Neurosurg Spine 14(2):143–150CrossRefPubMed

McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM (2001) Chordoma: incidence and survival patterns in the United States, 1973–1995[J]. Cancer Causes Control 12(1):1–11CrossRefPubMed

10.

Boriani S, Bandiera S, Biagini R, Bacchini P, Boriani L, Cappuccio M, Chevalley F, Gasbarrini A, Picci P, Weinstein JN (2006) Chordoma of the mobile spine: fifty years of experience[J]. Spine (Phila Pa 1976) 31(4):493–503CrossRef

11.

Staab A, Rutz HP, Ares C, Timmermann B, Schneider R, Bolsi A, Albertini F, Lomax A, Goitein G, Hug E (2011) Spot-scanning-based proton therapy for extracranial chordoma[J]. Int J Radiat Oncol Biol Phys 81(4):e489–e496CrossRefPubMed

12.

Stacchiotti S, Casali PG, Lo Vullo S, Mariani L, Palassini E, Mercuri M, Alberghini M, Pilotti S, Zanella L, Gronchi A, Picci P (2010) Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers[J]. Ann Surg Oncol 17(1):211–219CrossRefPubMed

13.

Clarke MJ, Dasenbrock H, Bydon A, Sciubba DM, McGirt MJ, Hsieh PC, Yassari R, Gokaslan ZL, Wolinsky JP (2012) Posterior-only approach for en bloc sacrectomy: clinical outcomes in 36 consecutive patients[J]. Neurosurgery 71(2):357–364 discussion 64CrossRefPubMed

14.

Wu Z, Zhang J, Zhang L, Jia G, Tang J, Wang L, Wang Z (2010) Prognostic factors for long-term outcome of patients with surgical resection of skull base chordomas-106 cases review in one institution[J]. Neurosurg Rev 33(4):451–456CrossRefPubMed

15.

Yasuda M, Bresson D, Chibbaro S, Cornelius JF, Polivka M, Feuvret L, Takayasu M, George B (2012) Chordomas of the skull base and cervical spine: clinical outcomes associated with a multimodal surgical resection combined with proton-beam radiation in 40 patients[J]. Neurosurg Rev 35(2):171–182 discussion 82–3CrossRefPubMed

16.

Ouyang T, Zhang N, Zhang Y, Jiao J, Ren J, Huang T, Chen J (2014) Clinical characteristics, immunohistochemistry, and outcomes of 77 patients with skull base chordomas[J]. World Neurosurg 81(5–6):790–797CrossRefPubMed

17.

Rachinger W, Eigenbrod S, Dutzmann S, Simon M, Feigl GC, Kremenevskaja N, Kretzschmar H, Zausinger S, Kreth FW, Thon N, Tonn JC (2014) Male sex as a risk factor for the clinical course of skull base chordomas[J]. J Neurosurg 120(6):1313–1320CrossRefPubMed

18.

Fuchs B, Dickey ID, Yaszemski MJ, Inwards CY, Sim FH (2005) Operative management of sacral chordoma[J]. J Bone Joint Surg Am 87(10):2211–2216

19.

Park L, Delaney TF, Liebsch NJ, Hornicek FJ, Goldberg S, Mankin H, Rosenberg AE, Rosenthal DI, Suit HD (2006) Sacral chordomas: impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor[J]. Int J Radiat Oncol Biol Phys 65(5):1514–1521CrossRefPubMed

20.

Yu E, Koffer PP, DiPetrillo TA, Kinsella TJ (2016) Incidence, treatment, and survival patterns for sacral chordoma in the United States, 1974–2011[J]. Front Oncol 6:203PubMedPubMedCentral

21.

Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, Meis-Kindblom JM (2000) Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients[J]. Cancer 88(9):2122–2134CrossRefPubMed

22.

Fuller DB, Bloom JG (1988) Radiotherapy for chordoma[J]. Int J Radiat Oncol Biol Phys 15(2):331–339CrossRef

23.

Gupta T, Wadasadawala T, Master Z, Phurailatpam R, Pai-Shetty R, Jalali R (2012) Encouraging early clinical outcomes with helical tomotherapy-based image-guided intensity-modulated radiation therapy for residual, recurrent, and/or progressive benign/low-grade intracranial tumors: a comprehensive evaluation[J]. Int J Radiat Oncol Biol Phys 82(2):756–764CrossRefPubMed

24.

Kano H, Iqbal FO, Sheehan J, Mathieu D, Seymour ZA, Niranjan A, Flickinger JC, Kondziolka D, Pollock BE, Rosseau G, Sneed PK, McDermott MW, Lunsford LD (2011) Stereotactic radiosurgery for chordoma: a report from the North American Gamma Knife Consortium[J]. Neurosurgery 68(2):379–389CrossRefPubMed

25.

Gutin PH, Leibel SA, Hosobuchi Y, Crumley RL, Edwards MS, Wilson CB, Lamb S, Weaver KA (1987) Brachytherapy of recurrent tumors of the skull base and spine with iodine-125 sources[J]. Neurosurgery 20(6):938–945CrossRefPubMed

26.

Catton C, O'Sullivan B, Bell R, Laperriere N, Cummings B, Fornasier V, Wunder J (1996) Chordoma: long-term follow-up after radical photon irradiation[J]. Radiother Oncol 41(1):67–72CrossRefPubMed

27.

Terahara A, Niemierko A, Goitein M, Finkelstein D, Hug E, Liebsch N, O'Farrell D, Lyons S, Munzenrider J (1999) Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma[J]. Int J Radiat Oncol Biol Phys 45(2):351–358CrossRefPubMed

28.

Alonso-Basanta M, Lustig RA, Kennedy DW (2011) Proton beam therapy in skull base pathology[J]. Otolaryngol Clin N Am 44(5):1173–1183CrossRef

29.

Noone AM, Lund JL, Mariotto A, Cronin K, McNeel T, Deapen D, Warren JL (2016) Comparison of SEER treatment data with medicare claims[J]. Med Care 54(9):e55–e64CrossRefPubMedPubMedCentral

30.

Stacchiotti S, Sommer J (2015) Chordoma Global Consensus G. Building a global consensus approach to chordoma: a position paper from the medical and patient community[J]. Lancet Oncol 16(2):e71–e83CrossRefPubMed

31.

Bosma JJ, Pigott TJ, Pennie BH, Jaffray DC (2001) En bloc removal of the lower lumbar vertebral body for chordoma. Report of two cases[J]. J Neurosurg 94(2 Suppl):284–291PubMed

32.

Hsu KY, Zucherman JF, Mortensen N, Johnston JO, Gartland J (2000) Follow-up evaluation of resected lumbar vertebral chordoma over 11 years: a case report[J]. Spine (Phila Pa 1976) 25(19):2537–2540CrossRef

33.

Chugh R, Tawbi H, Lucas DR, Biermann JS, Schuetze SM, Baker LH (2007) Chordoma: the nonsarcoma primary bone tumor[J]. Oncologist 12(11):1344–1350CrossRef

34.

Guinto G, Guinto-Nishimura Y (2014) Clivus chordomas: role of surgery[J]. World Neurosurg 81(5–6):688–689CrossRefPubMed

35.

DeLaney TF, Liebsch NJ, Pedlow FX, Adams J, Dean S, Yeap BY, McManus P, Rosenberg AE, Nielsen GP, Harmon DC, Spiro IJ, Raskin KA, Suit HD, Yoon SS, Hornicek FJ (2009) Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas[J]. Int J Radiat Oncol Biol Phys 74(3):732–739CrossRefPubMed

36.

Baratti D, Gronchi A, Pennacchioli E, Lozza L, Colecchia M, Fiore M, Santinami M (2003) Chordoma: natural history and results in 28 patients treated at a single institution[J]. Ann Surg Oncol 10(3):291–296CrossRefPubMed

37.

York JE, Kaczaraj A, Abi-Said D, Fuller GN, Skibber JM, Janjan NA, Gokaslan ZL (1999) Sacral chordoma: 40-year experience at a major cancer center[J]. Neurosurgery 44(1):74–79 discussion 9–80CrossRef

38.

Biermann JS, Chow W, Reed DR, Lucas D, Adkins DR, Agulnik M, Benjamin RS, Brigman B, Budd GT, Curry WT, Didwania A, Fabbri N, Hornicek FJ, Kuechle JB, Lindskog D, Mayerson J, McGarry SV, Million L, Morris CD, Movva S, O’Donnell RJ, Randall RL, Rose P, Santana VM, Satcher RL, Schwartz H, Siegel HJ, Thornton K, Villalobos V, Bergman MA, Scavone JL (2017) NCCN guidelines insights: bone cancer, version 2.2017[J]. J Natl Compr Cancer Netw 15(2):155–167CrossRef

39.

Foweraker KL, Burton KE, Maynard SE, Jena R, Jefferies SJ, Laing RJ, Burnet NG (2007) High-dose radiotherapy in the management of chordoma and chondrosarcoma of the skull base and cervical spine: part 1—clinical outcomes[J]. Clin Oncol (R Coll Radiol) 19(7):509–516CrossRef

40.

Mendenhall WM, Mendenhall CM, Lewis SB, Villaret DB, Mendenhall NP (2005) Skull base chordoma[J]. Head Neck 27(2):159–165CrossRefPubMed

41.

Chambers KJ, Lin DT, Meier J, Remenschneider A, Herr M, Gray ST (2014) Incidence and survival patterns of cranial chordoma in the United States[J]. Laryngoscope 124(5):1097–1102CrossRefPubMed

42.

Di Maio S, Rostomily R, Sekhar LN (2012) Current surgical outcomes for cranial base chordomas: cohort study of 95 patients[J]. Neurosurgery 70(6):1355–1360 discussion 60CrossRefPubMed

43.

Bugoci DM, Girvigian MR, Chen JC, Miller MM, Rahimian J (2013) Photon-based fractionated stereotactic radiotherapy for postoperative treatment of skull base chordomas[J]. Am J Clin Oncol 36(4):404–410CrossRefPubMed

44.

Ares C, Hug EB, Lomax AJ, Bolsi A, Timmermann B, Rutz HP, Schuller JC, Pedroni E, Goitein G (2009) Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report[J]. Int J Radiat Oncol Biol Phys 75(4):1111–1118CrossRefPubMed

45.

Crockard HA, Steel T, Plowman N, Singh A, Crossman J, Revesz T, Holton JL, Cheeseman A (2001) A multidisciplinary team approach to skull base chordomas[J]. J Neurosurg 95(2):175–183CrossRefPubMed

46.

Colli B, Al-Mefty O (2001) Chordomas of the craniocervical junction: follow-up review and prognostic factors[J]. J Neurosurg 95(6):933–943CrossRefPubMed

47.

Amer HZ, Hameed M (2010) Intraosseous benign notochordal cell tumor[J]. Arch Pathol Lab Med 134(2):283–288PubMed

48.

Jones PS, Aghi MK, Muzikansky A, Shih HA, Barker FG 2nd, Curry WT Jr (2014) Outcomes and patterns of care in adult skull base chondrosarcomas from the SEER database[J]. J Clin Neurosci 21(9):1497–1502CrossRefPubMed

49.

Cummings BJ, Hodson DI, Bush RS (1983) Chordoma: the results of megavoltage radiation therapy[J]. Int J Radiat Oncol Biol Phys 9(5):633–642CrossRef

50.

Holliday EB, Mitra HS, Somerson JS, Rhines LD, Mahajan A, Brown PD, Grosshans DR (2015) Postoperative proton therapy for chordomas and chondrosarcomas of the spine: adjuvant versus salvage radiation therapy[J]. Spine (Phila Pa 1976) 40(8):544–549CrossRef

51.

Lee J, Bhatia NN, Hoang BH, Ziogas A, Zell JA (2012) Analysis of prognostic factors for patients with chordoma with use of the California Cancer Registry[J]. J Bone Joint Surg Am 94(4):356–363CrossRef

Title: Survival analysis of patients with spinal chordomas
Authors: Hui-Hui Sun
Xin Hong
Bing Liu
Jia-Qu Cui
Zhao-Ming Zhou
Xin-Hui Xie
Xiao-Tao Wu
Publication date: 01-06-2019
Publisher: Springer Berlin Heidelberg
Published in: Neurosurgical Review / Issue 2/2019
Print ISSN: 0344-5607
Electronic ISSN: 1437-2320
DOI: https://doi.org/10.1007/s10143-018-0968-7

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Survival analysis of patients with spinal chordomas

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2019

MRI combined with PET-CT of different tracers to improve the accuracy of glioma diagnosis: a systematic review and meta-analysis

Secondary coiling after incomplete surgical clipping of cerebral aneurysms: a rescue strategy or a treatment option for complex cases? Institutional series and systematic review

Rate and risk factors for a hyperactivity delirium in patients with aneurysmal subarachnoid haemorrhage

Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma

Systemic autoimmune diseases complicated with hydrocephalus: pathogenesis and management

Clipping on sling-wrap method using a polyglycolic acid sheet in a thin-walled or atherosclerotic middle cerebral artery aneurysm: technique note